ResearcherUniversity of NottinghamActive in the last 2 years

Richard Ivell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6513-2109; OpenAlex author ID A5027934616. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fendo.2025.1625906 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Rüdiger Braun · 1 shared paper, 2025 · strength 0.33
- Paper Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma. DOI 10.3389/fendo.2025.1625906 ↗
Ravinder Anand‐Ivell · 1 shared paper, 2025 · strength 0.33
- Paper Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma. DOI 10.3389/fendo.2025.1625906 ↗
Hendrik Ungefroren · 1 shared paper, 2025 · strength 0.33
- Paper Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma. DOI 10.3389/fendo.2025.1625906 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.